Chemotherapeutic effect of Farnesol against N-Diethyl Nitrosamine (DEN) Induced Experimental Hepatocellular Carcinoma in Rats

Authors(5) :-Gopalakrishnan Balaraman, Ashok M, Satheesh Kanna V, PalanisamyK, Dr. Devaki T

Hepatocellular carcinoma (HCC), commonly known as liver cancer, is a most prevalent cancer which accounts for increased morbidity and mortality in developed countries. Currently available drugs for the treatment of liver cancer cause detrimental side effects. Hence search for plant - based drugs with fewer side effects continues. Farnesol which is found in the essential oils of ambrette seeds, citronella, and chamomile possess a wide range of pharmacological properties.  In the present study an attempt has been made to evaluate the anticancer effect of farnesol against DEN- induced hepatocellular carcinoma in rats. Oral treatment of  farnesol  (25 mg/kg bw) to tumor bearing rats daily for four weeks was found to be effective against DEN- induced hepatocellular carcinoma in rats. The levels of tumor markers such as alpha fetal protein and carcinoembryonic antigen were decreased upon farnesol treatment.  The increased levels of DNA and RNA were found to be decreased upon treatment with farnesol. There was a significant improvement in protein content. The increased activities of AST, ALT, ALP, ACP, 5’-ND, gamma-GT and LDH in serum of experimental rats were significantly decreased to near normal levels. Oral administration of farnesol to DEN- induced rats significantly decreased the levels of Phase I enzymes and increased the levels of Phase II enzymes in liver tissues to near normalcy. Elevated levels of glycocomponents of glycoproteins such as hexose, hexosamine and sialic acid in plasma and liver tissues were significantly decreased upon farnesol treatment.  The results of the present study indicate that farnesol exerts chemotherapeutic potential in DEN- induced hepatocellular carcinoma in rats.

Authors and Affiliations

Gopalakrishnan Balaraman
Department of Biochemistry, University of Madras, Guindy Campus, Chennai, Tamilnadu, India
Ashok M
Department of Biochemistry, University of Madras, Guindy Campus, Chennai, Tamilnadu, India
Satheesh Kanna V
Department of Biochemistry, University of Madras, Guindy Campus, Chennai, Tamilnadu, India
Department of Biochemistry, University of Madras, Guindy Campus, Chennai, Tamilnadu, India
Dr. Devaki T
Department of Biochemistry, University of Madras, Guindy Campus, Chennai, Tamilnadu, India

Hepatocellular Carcinoma, Diethyl Nitrosamine, Farnesol, Anticancer Property.

  1. DHashim, P.Boffetta: Occupational and environmental exposures and cancers in developing countries. Ann Glob Health, 80(5):393{411, 2014.
  2. FG.Peers, C.A. Linsell. Dietary aflatoxins and liver cancer--a population based study in Kenya. Br J Cancer, 27(6):473{84, 1973.
  3. KJ. Jeena, K.L.Joy, R.Kuttan. Effect of Emblica officinalis, Phyllanthus amarus and Picrorrhiza kurroa on N-nitrosodiethylamine induced hepatocarcinogenesis.Cancer Lett, 136(1):11{6, 1999.
  4. R Khan and S. Sultana. Farnesol attenuates 1, 2- dimethylhydrazine induced oxidative stress, inflammation and apoptotic responses in the colon of Wistar rats. Chem. Biol. Interact, 192: 193{200, 2011.
  5. D Tatman and H.Mo.Volatile isoprenoid constituents of fruits, vegetables and herbs cumulatively suppress the proliferation of Murine B16 melanoma and human HL-60 leukemia cells. Cancer Lett, 175:129{139, 2002.
  6. RDuncan and M. Archer.Farnesol decreases serum triglycerides in rats: identification of mechanisms including up-regulation of PPARa and down-regulation of fatty acid synthase in hepatocytes. Lipids, 43:619{627, 2008.
  7. JH. Joo and A.M. Jetten. Molecular mechanisms involved in farnesol-induced apoptosis. Cancer Lett, 287:123{135, 2010.
  8. OH. Lowry, N.J. Rosebrough, A.L. Farr and R.J. Randall.Protein measurement with the Folin phenol reagent.J Biol Chem,193:265{275,1951.
  9. WC. Schneider. Determination of nucleic acid in tissue by pentose analysis, in: Methods in Enzymology, vol. III Academic Press, New York, 680{775, 1957.
  10. K Burton. A study of the conditions and mechanisms of diphenylamine reaction for colorimetric estimation of deoxyribonucleic acid.Biochem. J, 62:315{323, 1956.
  11. VM. Rawal, V.S. Patel, G.N. Rao,R.R. Desai.Chemical and biochemical studies on cataractous human lenses e III e quantitative study of protein RNA and DNA, Arogya J. Health Sci, 3:69{75,1977.
  12. HU.Bergmeyer,P.Schiebe,A.W.Wahlefeld.Optimization of methods for aspartate aminotransferase and alanine aminotransferase. Clin. Chem, 24: 58{73, 1978.
  13. JKing, The phosphohydrolases-acid and alkaline phophatases. In Practical Clinical Enzymology, D.Van, (Ed.) Nostrand Company Ltd. London. 191{208, 1965.
  14. PLuly, O.Barnabei, E.Tria: Hormonal control in vitro of plasma membrane bound (Na+, K+) -ATPase of rat liver. Biochim. Biophys. Acta. 282: 447{52 1972.
  15. SB.Rosalki, D.Rau. Serum-glutamyl transpepidase activity in alcoholism. Clin. Chim. Acta. 39: 41{7 1972.
  16. JKing. The dehydrogenases or oxido reductase-lactacte dehydrogenase. In: Practical clinical Enzymology. London: D.Van, Nostrand Co. Ltd 83-93, 1965.
  17. TOmura, R.Sato. The carbon monoxide binding pigment of liver microsomes, J. Biol. Chem. 239: 2370 {2378, 1964.
  18. WH.Habig, M.J.Pabst, W.B.Jakoby. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation, J. Biol. Chem, 249: 7130{7139, 1974.
  19. KJ.Isselbacher, J.L.Dienstag. Carcinomas of the liver. In A.S.Fauci, E.Braunwald, K.J.Isselbacher, et al, eds. Harrison’s Principles of Internal Medicine. 14th ed. New York, McGraw-Hill; p.579 {80, 1998.
  20. PNiebes. Determination of enzyme and degradation products of GAG metabolism in the serum of healthy and various subjects. Clin Chim Acta 42: 399{408, 1972.
  21. WD. Wagner: More sensitive assay discriminating galactosamine and glucosamine in mixtures. Anal biochem ; 94:394{397, 1979.
  22. LWarren: The thiobarbituric acid assay of sialic acid. J. Biol Chem 234: 1971{1975, 1959.
  23. BP. Sullivan, T.J. Meyer, M.T. Stershic, L.K. Keefer LK. Acceleration of N-nitrosation reactions by electrophiles, l370 {374, 1991.
  24. VSivaramakrishnan, P.N.M.Shilpa, V.R.Praveen Kumar, S.Niranjali Devaraj. Attenuation of N-nitrosodiethylamine-induced hepatocellular carcinogenesis by a novel flavonol-Morin. Chemico-Biological Interactions. (2)171:79-88, 2008.
  25. GRamakrishnan, H.R.Raghavendran, R.Vinodhkumar, T.Devaki.Suppression of N-nitosodiethylamine induced hepatocarcinogenesis by silymarin in rats. Chem Biol Interact. 161(2):104{114, 2006.
  26. YP.Dragan,H.A.Campbell, K.Baker, J.Vaughan, M.Mass, H.C.Pitot. Focal and non-focal hepatic expression of placental glutathione S-transferase in carcinogen-treated rats. Carcinogenesis, 15(11):2587{2591, 1994.
  27. LVerna,J.Whysner,G.M.Williams. N-mitrosodiethylamine mechanistic data and risk assessment: bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation. Pharmacol Ther. 71(1-2):57{81, 1996.
  28. AS.Yu, E.B. Keeffe. Management of hepatocellular carcinoma. Rev Gastroenterol Disord. Winter,3(1):8{24, 2003.
  29. M. Di Maio, E. De Maio, F.Perrone, S.Pignata, B. Daniele. Hepatocellular carcinoma: systemic treatments. J Clin Gastroenterol: S109 {14, 2002.
  30. PE.Porporato. Understanding cachexia as a cancer metabolism syndrome. Oncogenesis, 5:2016.
  31. CP. Holroyde, C.L. Skutches, G.Boden, Reichard GA. Glucose metabolism in cachectic patients with colorectal cancer. Cancer Res. 44:5910{3,1984.
  32. NVoorzanger-Rousselot, P.Garnero. Biochemical markers in oncology. Part I: molecular basis. Part II: clinical uses. Cancer Treat Rev,33: 230{283, 2007.
  33. LWu, A.Hu, N.Tam, J.Zhang, M.Lin, Z.Guo, X.He. Salvage liver transplantation for patients with recurrent hepatocellular carcinoma after curative resection. PLoS One,7(7): 2012.
  34. Konstantopoulos, S.N.Thomas. Cancer cells in transit: the vascular interactions of tumor cells. Annu Rev Biomed Eng, 11: 177{202, 2009.
  35. DD. Banker. Viral hepatitis. Indian J Med Sci, 57:511{7, 2005.
  36. RE. Gallagher. Biochemistry of neoplasia. In: Comprehensive textbook of oncology. Moosa AR, Robson MC, Schimpff SC (eds). Baltimore, USA, Williams and Wilkins, 36{45, 1986.
  37. LTessitore, G.Bonelli, F.M. Baccino. Early development of protein metabolic perturbations in the liver and skeletal muscle of tumour-bearing rats. A model system for cancer cachexia. Biochem J,241(1):153{9, 1987.
  38. JM.Joseph, N.Gross, N.Lassau, V.Rouffiac, P.Opolon, L.Laudani, K.Auderset, J.F.Geay,A.Mühlethaler-Mottet, G .Vassal. In vivo echographic evidence of tumoral vascularization and microenvironment interactions in metastatic orthotopic human neuroblastoma xenografts. Int J Cancer, 113(6):881{90, 2005.
  39. YSun. Free radicals, antioxidant enzymes, and carcinogenesis. Free Radic Biol Med, 8:583{599, 1990.
  40. MH. Helmes, A.Modia, A.El-Moneim, M.S.Moustafe, A.EI-Balc, M .Safinoz. Clinical value of serum LDH, ceruloplasmin, cathepsin-D and lipid bound sialic acid in onitoring patients with malignant lymphomas. Med. Sci. Res,26: 613{ 617,1998.
  41. MJ. Zamek-Gliszczynski, K.A. Hoffmaster, K.Nezasa, M.N.Tallman, K.L.Brouwer. Integration of hepatic drug transporters and phase II metabolizing enzymes: mechanisms of hepatic excretion of sulfate, glucuronide, and glutathione metabolites. Eur J Pharm Sci, 27:447{486, 2006.
  42. SRendic. Summary of information on human CYP enzymes: human p450 metabolism data. Drug Meta Rev, 34:83{448, 2002.
  43. CIoannides, D.F.Lewis. Cytochromes p450 in the bioactivation of chemicals. Cur Top Med Chem, 4:1767{1788, 2004.
  44. VKrajka-Kuzniak. Induction of phase II enzymes as a strategy in the chemoprevention of cancer and other degenerative diseases. Postepy High Med Dosw, 61:627{638, 2007.
  45. SSrigopalram, S.Ilavenil, Indira, A.Jayraaj. Apoptosis associated inhibition of DEN-induced hepatocellular carcinogenesis by ellagic acid in experimental rats. Biomed Prev Nutr. 2:1–8 2012.
  46. NM Pakkir Maideen 1, R.Velayutham, G.Manavalan. Protective Effect of Prosopis cineraria Against N-Nitrosodiethylamine Induced Liver Tumor by Modulating Membrane Bound Enzymes and Glycoproteins. Adv Pharm Bull. 2012; 2(2):179{82. 2012.
  47. VManju, V.Balasubramanian, N.Nalini. Oxidative stress and tumour markers in cervical cancer patients. J Biochem Mol Biol Biophys, 6: 387{390, 2002.

Publication Details

Published in : Volume 4 | Issue 10 | September-October 2018
Date of Publication : 2018-10-30
License:  This work is licensed under a Creative Commons Attribution 4.0 International License.
Page(s) : 326-337
Manuscript Number : IJSRST1841082
Publisher : Technoscience Academy

Print ISSN : 2395-6011, Online ISSN : 2395-602X

Cite This Article :

Gopalakrishnan Balaraman, Ashok M, Satheesh Kanna V, PalanisamyK, Dr. Devaki T, " Chemotherapeutic effect of Farnesol against N-Diethyl Nitrosamine (DEN) Induced Experimental Hepatocellular Carcinoma in Rats", International Journal of Scientific Research in Science and Technology(IJSRST), Print ISSN : 2395-6011, Online ISSN : 2395-602X, Volume 4, Issue 10, pp.326-337, September-October-2018.
Journal URL :

Article Preview